Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database

Introduction: Epirubicin is widely used in many malignancies with good efficacy and tolerability. However, investigations about adverse events (AEs) using real-world information are still insufficient. Methods: We extracted Epirubicin-related reports submitted between the first quarter of 2014 and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Guan, Xin, Wang, Shuang, Shi, Lipeng, Zhu, Yanfei, Hua, Pengbo, Guo, Qiang, Wang, Jingqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536159/
https://www.ncbi.nlm.nih.gov/pubmed/37781696
http://dx.doi.org/10.3389/fphar.2023.1249845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536159/
https://www.ncbi.nlm.nih.gov/pubmed/37781696
http://dx.doi.org/10.3389/fphar.2023.1249845

Ejemplares similares